GSK has announced that its B7-H3-targeted antibody-drug conjugate, GSK5764227 (GSK'227), has been granted Orphan Drug Designation by the European Medicines Agency for treating pulmonary neuroendocrine carcinoma, including small-cell lung cancer...
Fidelity Asian Values has released its September 2025 factsheet, reporting a 12-month NAV increase of 11.0% and a share price gain of 19.1%, outperforming its reference index which rose by 7.9%...
Fidelity European Trust has published its September 2025 factsheet, noting European equities finished the quarter higher despite mixed sector performance...
REACT Group has issued a trading update for the year ended 30 September 2025, reporting revenue growth of 21% to approximately £25.0 million and adjusted EBITDA of at least £3.0 million, both ahead of market expectations...
Time Finance will issue its H1 FY2025/26 Trading Update on 16 December 2025. The Group reports continued strong demand and expects full-year results to be at least in line with market expectations...
Fidelity Special Values has released its September 2025 factsheet, highlighting continued gains in UK equities amid supportive monetary policy and firmer commodity prices...
European equity markets are seeing moderate gains at the outset of the week, supported by improving US‑China trade prospects and forthcoming central‑bank decisions...
LNG export growth and underground storage investment are converging to reshape the structure of global gas markets, with clear signals for long-term capital...
As of 30 September 2025, the trust outperformed its benchmark. Gains were supported by strong stock selection in construction, materials, and energy, with Tecnicas Reunidas and Puuilo contributing positively...
GSK has announced that its B7-H3-targeted antibody-drug conjugate, GSK5764227 (GSK'227), has been granted Orphan Drug Designation by the European Medicines Agency for treating pulmonary neuroendocrine carcinoma, including small-cell lung cancer...
Fidelity Asian Values has released its September 2025 factsheet, reporting a 12-month NAV increase of 11.0% and a share price gain of 19.1%, outperforming its reference index which rose by 7.9%...
Fidelity European Trust has published its September 2025 factsheet, noting European equities finished the quarter higher despite mixed sector performance...
REACT Group has issued a trading update for the year ended 30 September 2025, reporting revenue growth of 21% to approximately £25.0 million and adjusted EBITDA of at least £3.0 million, both ahead of market expectations...
Time Finance will issue its H1 FY2025/26 Trading Update on 16 December 2025. The Group reports continued strong demand and expects full-year results to be at least in line with market expectations...
Fidelity Special Values has released its September 2025 factsheet, highlighting continued gains in UK equities amid supportive monetary policy and firmer commodity prices...
European equity markets are seeing moderate gains at the outset of the week, supported by improving US‑China trade prospects and forthcoming central‑bank decisions...
LNG export growth and underground storage investment are converging to reshape the structure of global gas markets, with clear signals for long-term capital...
As of 30 September 2025, the trust outperformed its benchmark. Gains were supported by strong stock selection in construction, materials, and energy, with Tecnicas Reunidas and Puuilo contributing positively...
